Top

Published in:

01-01-2016 | Literatur kommentiert

Die stereotaktische Strahlentherapie unterstützt die Immunantwort

Author: Prof. Dr. med. Dr. Esther G. C. Troost, M.D., Ph.D.

Published in: Strahlentherapie und Onkologie | Issue 1/2016

Auszug

Sharabi AB, Nirschi CJ, Kochel C et al (2015) Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune response via cross-presentation of tumor antigen. Cancer Immunol Res 3(4):345–355 …

Chang JY, Senan S, Paul MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16:630–637PubMedCrossRef

De Ruysscher D, Wanders R, van Baardwijk A et al (2012) Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase ii trial (Nct01282450). J Thorac Oncol 7:1547–1555PubMedCrossRef

Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83:878–886PubMedCrossRef

Brahmer J, Reckamp KL, Baas P et al (2015) Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 373:123–135PubMedCrossRef

Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723PubMedPubMedCentralCrossRef

Rekers NH, Troost EG, Zegers CM, Germeraad WT, Dubois LJ, Lambin P (2014) Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives. Cancer Radiother 18:391–395PubMedCrossRef

Postow MA, Callahan MK, Barker CA et al (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366:925–931PubMedPubMedCentralCrossRef

Mole RH (1953) Whole body irradiation; radiobiology or medicine? Br J Radiol 26:234–241PubMedCrossRef

Kroemer G, Zitvogel L (2012) Abscopal but desirable: the contribution of immune responses to the efficacy of radiotherapy. Oncoimmunology 1:407–408PubMedPubMedCentralCrossRef

10.

Masucci GV, Wersall P, Kiessling R, Lundqvist A, Lewensohn R (2012) Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours. J Transl Med 10:104PubMedPubMedCentralCrossRef

11.

Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I (2012) The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys 85:293–295PubMedPubMedCentralCrossRef

12.

Diamond J, Pilones K, Aryankalayil J, Vatner R, Formenti SC, Demaria S (2014) Radiotherapy induces responsiveness of a resistant mammary carcinoa to PD-1 blockade. J Immunother Cancer 2:159CrossRef

13.

Binder DC, Fu YX, Weichselbaum RR (2015) Radiotherapy and immune checkpoint blockade: potential interactions and future directions. Trends Mol Med 21:463–465PubMedCrossRef

Title: Die stereotaktische Strahlentherapie unterstützt die Immunantwort
Author: Prof. Dr. med. Dr. Esther G. C. Troost, M.D., Ph.D.
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 1/2016
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-015-0923-2

ACC 2024 Congress

Springer Medicine

Die stereotaktische Strahlentherapie unterstützt die Immunantwort

Auszug

ACC 2024 Congress

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 1/2016

Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck

Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer

In memoriam Prof. Dr. Hans-Jürgen Eichhorn

Akuttoxizität nach hypofraktionierter versus konventionell fraktionierter Strahlentherapie bei Patienten mit Prostatakarzinom

Risk profile for osteoradionecrosis of the mandible in the IMRT era

Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery